Inside-Filings
Projekt anfragen

Whitehawk Therapeutics, Inc. (WHWK)

Whitehawk Therapeutics, Inc.
Healthcare · Biotechnology
TickerWHWKBörseNasdaq
ISINUS00032Q1040CIK0001422142
4,16
Schluss · 12.06.2026
1T+2,5 %1W+0,2 %1M−15,6 %3M+6,4 %6M+79,3 %1J+103,9 %
GCS 55 → +0,0
TSI -1,7 · 2,4 ▼ 01.06.
8-K 5.02 28.03.23· 1174T
Insider ▼ 16.04.26· 59T
PDF

Glück Conviction Score™ ⓘ

WHWK Whitehawk Therapeutics, Inc.
Conviction Score
55
Neutral
Effektiv: Neutral Niedrig
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
54,3
19 neu, 16 erhöht, 39,2M $ netto
Aktivist
0,0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)

Score-Verlauf (90 Tage)

Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.

Kursverlauf (12 Monate)

Technische Indikatoren

67.5
Technical-Score: 67.5 / 100 (informativ, keine Anlageempfehlung)
Bullisch-Anteil 45.5 % — 5 bullisch / 1 bärisch / 5 neutral

Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).

IndikatorSignalGewichtWertDetailBeitrag
Kurs vs SMA50Bullisch10 %4.14+0.5 % vs SMA50
Kurs vs SMA200Bullisch15 %2.97+40.2 % vs SMA200
EMA20 vs EMA50Bullisch5 %4.26EMA50: 4.11
MACD-HistogrammBärisch10 %-0.064Bearisch
RSI(14)Neutral10 %47.9Neutral (30–70)
Stoch %K(14)Bullisch5 %16.0Überverkauft
ADX(14)+DINeutral10 %17.8+DI: 31.4 / −DI: 21.3
Z-Score(60)Neutral5 %0.29In Range
52W-PositionNeutral5 %73.1 %Hoch 5.10 / Tief 1.60
Bollinger(20,2σ)Neutral5 %31.3 %Upper 4.88 / Mid 4.36 / Lower 3.83
LinReg-Slope(60)Bullisch10 %+0.0178R²=0.52 / annualisiert +111.4 %

Insider-Transaktionen (12 Monate) ⓘ

DatumInsiderRolleTypStückzahlKursWert (USD)ΔTrend
2026-04-16Giacobello Scott M.Officer, CHIEF FINANCIAL OFFICEROpen Market Sale-141.6004,13-584.808,00-316,8%
2026-04-15Giacobello Scott M.Officer, CHIEF FINANCIAL OFFICEROpen Market Sale-77.0003,86-297.220,00-161,0%
2026-04-14BALL BRYANOfficer, See remarksOpen Market Sale-92.4603,64-336.554,40-182,3%
2026-04-13BALL BRYANOfficer, See remarksOpen Market Sale-26.3893,46-91.305,94-49,5%
2026-04-10BALL BRYANOfficer, See remarksOpen Market Sale-6.5963,43-22.624,28-12,3%
2026-04-09Lennon David JamesDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-14.5003,38-49.010,00-26,5%
2026-04-09BALL BRYANOfficer, See remarksOpen Market Sale-50.0003,57-178.500,00-96,7%
2026-04-08Lennon David JamesDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-63.9453,40-217.413,00-117,8%
2026-04-07Lennon David JamesDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-94.0873,43-322.718,41-174,8%
2026-04-06Lennon David JamesDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-102.3953,51-359.406,45-194,7%
2026-04-02Lennon David JamesDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-26.8583,48-93.465,84-50,6%
2026-03-02BALL BRYANOfficer, See remarksOpen Market Sale-1.8343,31-6.069,81-3,3%
2026-03-02Lennon David JamesDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-5.1003,31-16.878,96-9,1%
2026-03-02Giacobello Scott M.Officer, CHIEF FINANCIAL OFFICEROpen Market Sale-2.5943,31-8.585,10-4,7%

Fondsaktivität (Vorquartalsvergleich) ⓘ

FondsAktuell (Stk)Vorquartal (Stk)Veränderung (Stk)Wert (USD)StatusΔTrend
QVT Financial LP4.615.7094.615.709015.924.196Unverändert0,0%
ORBIMED ADVISORS LLC4.166.0004.166.000014.372.700Unverändert0,0%
SUVRETTA CAPITAL MANAGEMENT, LLC3.700.0003.700.000012.765.000Unverändert0,0%
ACUTA CAPITAL PARTNERS, LLC3.410.4023.410.402011.765.887Unverändert0,0%
Avoro Capital Advisors LLC2.849.4022.849.40209.830.437Unverändert0,0%
KVP Capital Advisors, LP2.165.9972.165.99707.472.690Unverändert0,0%
Siren, L.L.C.2.082.0002.082.00007.182.900Unverändert0,0%
Yu Fan2.070.0002.070.00007.141.500Unverändert0,0%
VANGUARD CAPITAL MANAGEMENT LLC1.315.77001.315.7704.539.407Neu+100,0%
ACORN CAPITAL ADVISORS, LLC1.139.3631.139.36303.930.802Unverändert0,0%
VANGUARD GROUP INC1.590.11701.590.1173.848.082Neu+100,0%
STEMPOINT CAPITAL LP939.3691.458.807-519.4383.240.823Reduziert-35,6%
Ally Bridge Group (NY) LLC817.939817.93902.821.890Unverändert0,0%
BALYASNY ASSET MANAGEMENT L.P.550.4410550.4411.899.021Neu+100,0%
GEODE CAPITAL MANAGEMENT, LLC457.540425.44032.1001.579.172Aufgestockt+7,5%
RENAISSANCE TECHNOLOGIES LLC428.622440.722-12.1001.478.746Reduziert-2,7%
AMES NATIONAL CORP4.57104.5711.333.269Neu+100,0%
BlackRock, Inc.351.385299.01152.3741.212.278Aufgestockt+17,5%
MILLENNIUM MANAGEMENT LLC309.6740309.6741.068.375Neu+100,0%
Eversept Partners, LP306.800260.25946.5411.058.460Aufgestockt+17,9%
Woodline Partners LP281.4970281.497971.165Neu+100,0%
TWO SIGMA INVESTMENTS, LP273.482309.865-36.383943.513Reduziert-11,7%
BRIDGEWAY CAPITAL MANAGEMENT, LLC215.284215.2840742.730Unverändert0,0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP203.465110.08393.382701.954Aufgestockt+84,8%
JANE STREET GROUP, LLC171.11069.931101.179590.330Aufgestockt+144,7%
STATE STREET CORP160.382145.53714.845553.318Aufgestockt+10,2%
ADAR1 Capital Management, LLC128.50377.59350.910443.335Aufgestockt+65,6%
Verdad Advisers, LP115.4840115.484398.420Neu+100,0%
NORTHERN TRUST CORP107.266103.4523.814370.067Aufgestockt+3,7%
CITADEL ADVISORS LLC91.85298.950-7.098316.889Reduziert-7,2%
Hudson Bay Capital Management LP57.597057.597198.710Neu+100,0%
GOLDMAN SACHS GROUP INC56.912056.912196.346Neu+100,0%
Seven Fleet Capital Management LP54.296054.296187.321Neu+100,0%
BANK OF AMERICA CORP /DE/52.86141152.450182.370Aufgestockt+12761,6%
Qube Research & Technologies Ltd48.30772.348-24.041166.659Reduziert-33,2%
MARSHALL WACE, LLP67.959067.959164.461Neu+100,0%
BAILARD, INC.31.398031.398108.323Neu+100,0%
DIMENSIONAL FUND ADVISORS LP30.09028.6411.449103.810Aufgestockt+5,1%
TWO SIGMA ADVISERS, LP42.400042.400102.608Neu+100,0%
Point72 Asset Management, L.P.28.026028.02696.690Neu+100,0%
Catalyst Funds Management Pty Ltd27.011027.01193.188Neu+100,0%
OCCUDO QUANTITATIVE STRATEGIES LP22.291022.29189.387Neu+100,0%
XTX Topco Ltd22.98315.7047.27979.291Aufgestockt+46,4%
ABG Innovation Capital Partners III GP Ltd26.666026.66664.532Neu+100,0%
Brevan Howard Capital Management LP12.589012.58943.432Neu+100,0%
OMERS ADMINISTRATION Corp11.500011.50039.675Neu+100,0%
UBS Group AG11.43829.844-18.40639.461Reduziert-61,7%
PRELUDE CAPITAL MANAGEMENT, LLC10.28318.796-8.51335.476Reduziert-45,3%
MORGAN STANLEY8.3426.7481.59428.780Aufgestockt+23,6%
Quadrature Capital Ltd11.447011.44727.702Neu+100,0%

Top-Fondshalter (Stand: 31.03.2026) ⓘ

FondsAnteileVorquartal (Stk)ΔWert (USD)Anteil (%)
QVT Financial LP4.615.7094.615.7090,0%15.924.19613,45
ORBIMED ADVISORS LLC4.166.0004.166.0000,0%14.372.70012,14
SUVRETTA CAPITAL MANAGEMENT, LLC3.700.0003.700.0000,0%12.765.00010,78
ACUTA CAPITAL PARTNERS, LLC3.410.4023.410.4020,0%11.765.8879,94
Avoro Capital Advisors LLC2.849.4022.849.4020,0%9.830.4378,30
KVP Capital Advisors, LP2.165.9972.165.9970,0%7.472.6906,31
Siren, L.L.C.2.082.0002.082.0000,0%7.182.9006,07
Yu Fan2.070.0002.070.0000,0%7.141.5006,03
VANGUARD CAPITAL MANAGEMENT LLC1.315.7700+100,0%4.539.4073,83
ACORN CAPITAL ADVISORS, LLC1.139.3631.139.3630,0%3.930.8023,32
STEMPOINT CAPITAL LP939.3691.458.807-35,6%3.240.8232,74
Ally Bridge Group (NY) LLC817.939817.9390,0%2.821.8902,38
BALYASNY ASSET MANAGEMENT L.P.550.4410+100,0%1.899.0211,60
GEODE CAPITAL MANAGEMENT, LLC457.540425.440+7,5%1.579.1721,33
RENAISSANCE TECHNOLOGIES LLC428.622440.722-2,7%1.478.7461,25
AMES NATIONAL CORP4.5710+100,0%1.333.2691,13
BlackRock, Inc.351.385299.011+17,5%1.212.2781,02
MILLENNIUM MANAGEMENT LLC309.6740+100,0%1.068.3750,90
Eversept Partners, LP306.800260.259+17,9%1.058.4600,89
Woodline Partners LP281.4970+100,0%971.1650,82

Halter-Trend (6 Quartale)

PeriodeStatusHalterAnteile (Mio)Wert (Mio $)
31.03.2026✓6436,9128
31.12.2025✓4935,986
30.09.2025✓4128,854
30.06.2025✓4029,555
31.03.2025✓5135,162
31.12.2024✓5217,355

Top 10 Neueinsteiger

FondsAnteileWert (USD) ⓘ
KVP Capital Advisors, LP2.165.9975.241.714
TWO SIGMA INVESTMENTS, LP309.865749.873
Eversept Partners, LP260.259629.827
SUSQUEHANNA INTERNATIONAL GROUP, LLP110.083266.401
ADAR1 Capital Management, LLC77.593187.775
Qube Research & Technologies Ltd72.348175.082
MARSHALL WACE, LLP67.959164.461
TWO SIGMA ADVISERS, LP42.400102.608
PRELUDE CAPITAL MANAGEMENT, LLC18.79645.486
Quadrature Capital Ltd11.44727.702

Top 10 Aufstocker

FondsAnteileΔ Anteile ⓘΔ % ⓘWert (USD) ⓘ
STEMPOINT CAPITAL LP1.458.8071.034.725+244.0 %3.530.313
VANGUARD GROUP INC1.590.117247.210+18.4 %3.848.082
STATE STREET CORP145.53776.800+111.7 %352.200
JANE STREET GROUP, LLC69.93144.716+177.3 %169.233
GEODE CAPITAL MANAGEMENT, LLC425.44043.686+11.4 %1.030.005
NORTHERN TRUST CORP103.45231.288+43.4 %250.354
UBS Group AG29.84424.151+424.2 %72.222
MORGAN STANLEY6.7484.899+265.0 %16.331
BlackRock, Inc.299.0112.853+1.0 %723.607
SIMPLEX TRADING, LLC1.300965+288.1 %3.146

Top 10 Verkäufer

FondsAnteileΔ Anteile ⓘΔ % ⓘWert (USD) ⓘ
CITADEL ADVISORS LLC98.950-41.270-29.4 %239.459
RENAISSANCE TECHNOLOGIES LLC440.722-16.700-3.7 %1.066.547
DIMENSIONAL FUND ADVISORS LP28.641-15.474-35.1 %69.312
XTX Topco Ltd15.704-4.076-20.6 %38.004
ACADIAN ASSET MANAGEMENT LLC24.634-1.572-6.0 %58
JPMORGAN CHASE & CO121-300-71.3 %293

Aktivisten & Großaktionäre (13D/13G) ⓘ

DatumInvestorTypAnteilAktienΔZweck
18.05.2026ANUPAM DALALAktivist (13D/A)9,00 %4.843.775NeuThe reporting persons are filing this Schedule 13D because Mr. Dalal is on the Issuer's …
18.05.2026Acuta Capital Fund, LPAktivist (13D/A)6,60 %3.538.288+0,20 ppThe reporting persons are filing this Schedule 13D because Mr. Dalal is on the Issuer's …
18.05.2026ACUTA CAPITAL PARTNERS, LLCAktivist (13D/A)8,70 %4.685.912+1,20 ppThe reporting persons are filing this Schedule 13D because Mr. Dalal is on the Issuer's …
15.05.2026Avoro Capital Advisors LLCAktivist (13D/A)19,99 %15.893.516NeuOn May 12, 2026, the Issuer entered into a Securities Purchase Agreement (the "2026 Secu…
15.05.2026Avoro Ventures LLCAktivist (13D/A)4,10 %2.288.950NeuOn May 12, 2026, the Issuer entered into a Securities Purchase Agreement (the "2026 Secu…
15.05.2026Behzad AghazadehAktivist (13D/A)19,99 %18.292.675NeuOn May 12, 2026, the Issuer entered into a Securities Purchase Agreement (the "2026 Secu…
25.08.2025Matthew D. PerryPassiv (13G)5,98 %2.819.215Neu
25.08.2025Coastlands Capital Partners LPPassiv (13G)5,98 %2.819.215Neu
25.08.2025Coastlands Capital LPPassiv (13G)5,98 %2.819.215Neu
25.08.2025Coastlands Capital LLCPassiv (13G)5,98 %2.819.215Neu
25.08.2025Coastlands Capital GP LLCPassiv (13G)5,98 %2.819.215Neu
15.05.2025OrbiMed Advisors LLCPassiv (13G)8,90 %4.166.000-2,10 pp
15.05.2025OrbiMed Genesis GP LLCPassiv (13G)8,90 %4.166.000Neu
15.05.2025Point72 Capital Advisors, Inc.Passiv (13G/A)0,00 %5.087-6,00 pp
15.05.2025Point72 Asset Management, L.P.Passiv (13G/A)0,00 %5.087-6,00 pp
15.05.2025Steven A. CohenPassiv (13G/A)0,00 %5.087-6,00 pp
11.03.2025Averill Master Fund, Ltd.Passiv (13G)8,90 %4.189.490Neu
11.03.2025Cowen AaronPassiv (13G)9,99 %4.727.510Neu
11.03.2025SUVRETTA CAPITAL MANAGEMENT, LLCPassiv (13G)9,99 %4.727.510Neu
10.03.2025Fan YuPassiv (13G)6,30 %2.914.605Neu
10.03.2025ABG-SIV, L.P.Passiv (13G)4,50 %2.070.000Neu
10.03.2025ABG Innovation Capital Partners III GP LimitedPassiv (13G)0,10 %26.666Neu
10.03.2025ABG Management Ltd.Passiv (13G)1,80 %817.939Neu
10.03.2025ABG Global Life Science Capital Partners V GP, L.P.Passiv (13G)4,50 %2.070.000Neu
10.03.2025ABG Innovation-SO LimitedPassiv (13G)0,10 %26.666Neu
10.03.2025ABG Global Life Science Capital Partners V GP LimitedPassiv (13G)4,50 %2.070.000Neu
10.03.2025ABG Innovation Capital Partners III GP, L.P.Passiv (13G)0,10 %26.666Neu
10.03.2025Ally Bridge MedAlpha Master Fund L.P.Passiv (13G)1,80 %817.939Neu
10.03.2025Ally Bridge Group Global Life Science Capital Partners V, L.P.Passiv (13G)4,50 %2.070.000Neu
10.03.2025Ally Bridge Group (NY) LLCPassiv (13G)1,80 %817.939Neu
10.03.2025Ally Bridge Group Innovation Capital Partners III, L.P.Passiv (13G)0,10 %26.666Neu
10.03.2025ABG V-SIV LimitedPassiv (13G)4,50 %2.070.000Neu
06.03.2025Neil DesaiAktivist (13D/A)4,90 %2.272.941-4,30 pp
05.03.2025BML Investment Partners, L.P.Aktivist (13D/A)4,25 %1.971.137-4,25 ppOn February 28, 2025, the Issuer obtaned the Required Stockholder Approval for the 2024 …
05.03.2025Leonard Braden MichaelAktivist (13D/A)4,98 %2.435.000-4,92 ppOn February 28, 2025, the Issuer obtaned the Required Stockholder Approval for the 2024 …
04.03.2025AVORO CAPITAL ADVISORS LLCAktivist (13D/A)18,00 %9.515.802+6,40 ppOn February 28, 2025, the Issuer obtained the Required Stockholder Approval for the 2024…
04.03.2025BEHZAD AGHAZADEHAktivist (13D/A)19,99 %11.914.961+5,49 ppOn February 28, 2025, the Issuer obtained the Required Stockholder Approval for the 2024…
04.03.2025AVORO VENTURES LLCAktivist (13D/A)4,80 %2.288.950+2,30 ppOn February 28, 2025, the Issuer obtained the Required Stockholder Approval for the 2024…
24.02.2025BML Investment Partners, L.P.Aktivist (13D/A)8,50 %2.100.0000,00 ppThe Reporting Persons purchased the Common Stock reported hereunder for investment purpo…
24.02.2025Leonard Braden MichaelAktivist (13D/A)9,90 %2.435.0000,00 ppThe Reporting Persons purchased the Common Stock reported hereunder for investment purpo…

Stammdaten

Whitehawk Therapeutics Inc ist ein klinisches Biopharmaunternehmen, das Präzisions-Therapeutika für genetisch definierte Krebserkrankungen entwickelt.

Unternehmen & Branche

NameWhitehawk Therapeutics, Inc.
TickerWHWK
CIK0001422142
BoerseNasdaq
SektorHealthcare
IndustrieBiotechnology
SIC2834 · Pharmaceutical Preparations

Wertpapier & Kennzahlen

CUSIP00032Q104
ISINUS00032Q1040
TypCommon Stock
Marktkapitalisierung190,9 Mio. USD
Beta0,75

Bewertung

KBV (P/B)1,40 vs. 3,70 (2021) ▼
KUV (P/S)26,72 vs. 36,04 (2021) ▼
FCF-Rendite-51,3 % vs. -4,5 % (2021) ▼

Qualität & Bilanz

Bruttomarge89,4 % vs. 100,0 % (2021) ▼
Operative Marge-1.601,1 % vs. -794,4 % (2021) ▼
Nettomarge-288,3 % vs. -786,4 % (2021) ▲
ROIC-15,1 % vs. -80,4 % (2021) ▲

Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →

Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
Kennzahl20212022202320242025Verlauf
Bewertung
KBV (P/B)3,701,980,471,490,84
KUV (P/S)36,0420,602,043,0015,97
FCF-Rendite-4,5 %-16,0 %-128,3 %-78,5 %-85,9 %
Qualität & Bilanz
Bruttomarge100,0 %91,2 %88,5 %88,4 %89,4 %
Operative Marge-794,4 %-411,9 %-295,4 %-259,6 %-1.601,1 %
Nettomarge-786,4 %-397,7 %-270,0 %-245,1 %-288,3 %
ROIC-80,4 %-37,8 %-61,8 %-119,5 %-15,1 %
Zinsdeckungsgrad-167,2-272,5-311,4-438,0–

Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).

Externe Quelle: SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »

Finanzkennzahlen (SEC XBRL) ⓘ

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2026-03-3110-Q0-22.194.000-0,32127.231.000116.175.000
2025-12-3110-K7.145.000-20.596.000-0,33150.830.000136.311.000
2025-09-3010-Q0-17.746.000-0,26167.017.000157.168.000
2025-06-3010-Q0-52.615.000-0,76180.822.000172.066.000
2025-03-3110-Q7.145.00073.016.0001,83234.002.000221.728.000
2024-12-3110-K25.983.000-63.691.000-2,3670.319.00052.478.000
2024-09-3010-Q7.212.000-12.546.000-0,4685.698.00068.868.000
2024-06-3010-Q6.179.000-14.583.000-0,54101.620.00078.791.000
2024-03-3110-Q5.353.000-18.289.000-0,68111.073.00090.460.000
2023-12-3110-K24.354.000-65.765.000-2,44132.423.000105.195.000
2023-09-3010-Q5.959.000-16.302.000-0,60139.659.000118.196.000
2023-06-3010-Q6.202.000-17.971.000-0,67151.228.000131.419.000
2023-03-3110-Q5.867.000-15.223.000-0,57170.654.000145.986.000
2022-12-3110-K15.216.000-60.513.000-2,69184.237.000158.378.000
2022-09-3010-Q4.245.000-14.474.000-0,68194.103.000169.108.000
2022-06-3010-Q3.437.000-18.269.000-0,87128.636.000108.730.000
2022-03-3110-Q2.307.000-13.857.000-0,66142.319.000124.628.000
2021-12-3110-Q14.000.000157.910.000136.406.000
2021-12-3110-K14.000.000-110.090.000-12,41157.910.000136.406.000
2021-11-3010-Q1.000.000

Umsatz nach Segmenten & Regionen ⓘ

Geschäftssegmente

SegmentFY 2025FY 2024FY 2023FY 2022FY 2021AnteilΔTrend
Product7,1 Mio.26,0 Mio.24,4 Mio.15,2 Mio.–100,0 %-72,5%
License––––1,0 Mio.––
Grant––––120.000––

Quartalsergebnisse (Earnings) ⓘ

QuartalStichtagVerkündetUmsatzEPS
Q1 202631.03.202607.05.20260 USD-0,32
Q3 202530.09.202506.11.20250 USD-0,26
Q2 202530.06.202506.11.20250 USD-0,76
Q1 202531.03.202507.05.20267,1 Mio. USD1,83
Q3 202430.09.202406.11.20257,2 Mio. USD-0,46
Q2 202430.06.202406.11.20256,2 Mio. USD-0,54
Q1 202431.03.202406.11.20255,4 Mio. USD-0,68
Q3 202330.09.202306.11.20246,0 Mio. USD-0,60
Q2 202330.06.202306.11.20246,2 Mio. USD-0,67

Einreichungs-Historie (10-K / 10-Q)

SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte (10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die Tage zwischen Berichtsstichtag und tatsächlicher Einreichung. Suffix /A kennzeichnet nachträgliche Berichtigungen.

Eingereicht Form Berichtsperiode Verzögerung
07.05.2026 10-Q – – SEC »
12.03.2026 10-K 31.12.2025 71 Tage SEC »
06.11.2025 10-Q 30.09.2025 37 Tage SEC »
07.08.2025 10-Q 30.06.2025 38 Tage SEC »
08.05.2025 10-Q 31.03.2025 38 Tage SEC »
28.03.2025 10-K 31.12.2024 87 Tage SEC »
06.11.2024 10-Q 30.09.2024 37 Tage SEC »
07.08.2024 10-Q 30.06.2024 38 Tage SEC »
08.05.2024 10-Q 31.03.2024 38 Tage SEC »
13.03.2024 10-K 31.12.2023 73 Tage SEC »
08.11.2023 10-Q 30.09.2023 39 Tage SEC »
09.08.2023 10-Q 30.06.2023 40 Tage SEC »
10.05.2023 10-Q 31.03.2023 40 Tage SEC »
29.03.2023 10-K 31.12.2022 88 Tage SEC »
09.11.2022 10-Q 30.09.2022 40 Tage SEC »
10.08.2022 10-Q 30.06.2022 41 Tage SEC »
12.05.2022 10-Q 31.03.2022 42 Tage SEC »
17.03.2022 10-K 31.12.2021 76 Tage SEC »
10.11.2021 10-Q 30.09.2021 41 Tage SEC »
11.08.2021 10-Q 30.06.2021 42 Tage SEC »
17.05.2021 10-Q 31.03.2021 47 Tage SEC »
11.03.2021 10-K 31.12.2020 70 Tage SEC »
10.11.2020 10-Q 30.09.2020 41 Tage SEC »
12.08.2020 10-Q 30.06.2020 43 Tage SEC »

Kritische 8-K Meldungen ⓘ

DatumMeldungSchwereFilingAuszug
28.03.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSECon Form 8-K/A (“Amendment No. 1”) amends Item 5.02 of the Company’s Current Report on Form 8-K filed on March 3, 2023…
28.03.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSECby specific reference in such a filing. Item 5.02. Departure of Directors or Certain Officers; Election of Directors…
01.11.2021Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02(c) is incorporated herein by reference. (c) On November 1, 2021, Aadi Bioscience, Inc. (the “Company”)…
27.08.2021Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02. The newly appointed non-employee directors are expected to receive compensation and equity awards pursuant…

Fail-to-Deliver (6 Monate) ⓘ

DatumFTD-MengeKursWert (USD)
2026-05-143994,931.967
2026-04-06104.1003,51365.391
2026-04-0282.2423,54291.137
2026-03-0418.6143,3061.426
2026-03-0318.6143,2460.309
2026-02-265503,301.815
2025-12-3118.8122,4746.466
2025-12-221.9192,564.913
2025-12-191.6352,423.957
2025-12-182.0652,304.750

Hinweis

Erweitert ×